Mark Krul

Mark Krul is the current director at Macrophage Pharma. Prior to this, they were with Cristal Therapeutics, ISA Pharmaceuticals B.V., Aglaia Oncology Fund II, and Macrophage Pharma Ltd. Mark has also worked as a research manager at the European Cancer Center. Mark has over 25 years of experience in the pharmaceutical industry, with a focus on oncology drug development.

Mark Krul attended the Katholiek Gelders Lyceum, Arnhem for high school and then went on to Utrecht University where they obtained their Ph.D. in medical biology.